{
    "relation": [
        [
            "Treatments",
            "insulin",
            "glucosamine",
            "glucose"
        ],
        [
            "Referenced Treatments",
            "",
            "insulin",
            "insulin"
        ],
        [
            "Manipulated Protein",
            "",
            "",
            ""
        ],
        [
            "Referenced Protein",
            "",
            "",
            ""
        ],
        [
            "Effect",
            "increase",
            "inhibit treatment-induced increase",
            "augment treatment-induced increase"
        ],
        [
            "Notes",
            "",
            "",
            "High glucose concentrations (25 mM)"
        ]
    ],
    "pageTitle": "Curated Information",
    "title": "",
    "url": "http://www.phosphosite.org/curatedInfoAction.do?record=3357",
    "hasHeader": true,
    "headerPosition": "FIRST_ROW",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042981460.12/warc/CC-MAIN-20150728002301-00341-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 640631327,
    "recordOffset": 640616028,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "\u00a0Potential in vivo enzymes for site:\u00a0 Upstream Regulation \u00a0Species studied:\u00a0 rat \u00a0Cellular systems studied:\u00a0 cell lines \u00a0Relevant cell lines - cell types - tissues:\u00a0 RIN (epithelial) \u00a0Methods used to characterize site in vivo:\u00a0 phospho-antibody, western blotting Characterization IRS1\u00a0(human): S312\u2011p, IRS1\u00a0(mouse): S307\u2011p, IRS1\u00a0(rat): S307\u2011p Orthologous residues \u25b2 S312-p\u00a0-\u00a0IRS1 (human) Only sites from this record are displayed on this page. Click on the protein name to open the protein page, and on the RSD number to open the site page. For the complete dataset, click the download button, on the right.",
    "textAfterTable": "increase High glucose concentrations (25 mM) azaserine glucose inhibit treatment-induced increase High glucose concentrations (25 mM) glucosamine increase JNK inhibitor I glucosamine inhibit treatment-induced increase Y612-p\u00a0-\u00a0IRS1 (human) \u25b2 Orthologous residues IRS1\u00a0(human): Y612\u2011p, IRS1\u00a0(mouse): Y608\u2011p, IRS1\u00a0(rat): Y608\u2011p Characterization \u00a0Methods used to characterize site in vivo:\u00a0 phospho-antibody, western blotting \u00a0Relevant cell lines - cell types - tissues:\u00a0 RIN (epithelial)",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}